Is Intravenous Heparin a Contraindication for TPA in Ischemic Stroke?
There are approximately 2 million cardiac catheterizations that occur every year in the United States and with an aging population this number continues to rise. Adverse events due to this procedure occur at low rates and include stroke, arrhythmia, and myocardial infarctions. Due to the high volume...
Main Authors: | Zain Kulairi, Nisha Deol, Renee Tolly, Rohan Manocha, Maliha Naseer |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | Case Reports in Neurological Medicine |
Online Access: | http://dx.doi.org/10.1155/2017/9280961 |
Similar Items
-
QT Prolongation due to Graves’ Disease
by: Zain Kulairi, et al.
Published: (2017-01-01) -
Stercoral colitis complicated with ischemic colitis: a double-edge sword
by: Maliha Naseer, et al.
Published: (2017-11-01) -
Benefit and risk of early intravenous heparin after thrombolysis in patients with acute ischemic stroke
by: Xu Tong, et al.
Published: (2020-10-01) -
Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke
by: Chapman SN, et al.
Published: (2014-02-01) -
The safety and efficacy of tPA intravenous thrombolysis for treating acute ischemic stroke patients with a history of cerebral hemorrhage
by: Guang-jian Zhao, et al.
Published: (2019-01-01)